Cell Therapeutics, Incorporated

Seattle, Washington 98119

0 studies enrolling now · 2 studies all time

What they study most

Leukemia, Lung Cancer, Lymphoma

Studies at this site

• Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma — Withdrawn before enrolling
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Stopped early